Related Experiment Video
Updated: Jun 2, 2026
07:46
Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation
Published on: April 3, 2017
Immunologic profile of excessive body weight
Mansour Taghavi Azar Sharabiani1, Roel Vermeulen, Chiara Scoccianti
1School of Public Health, Imperial College London, London, UK.
Summary
This study identified key immune system markers, including Interleukin 8 (IL-8) and IL-10, that predict excessive body weight. These findings may help in understanding obesity
Area of Science:
- Immunology
- Obesity Research
- Biostatistics
Background:
- Excessive body weight, encompassing obesity and overweight, is linked to significant health issues.
- Understanding the immunologic underpinnings of excessive body weight is crucial for developing targeted interventions.
Purpose of the Study:
- To identify specific immunologic hallmarks associated with excessive body weight.
- To determine a predictive immunologic signature for obesity and overweight conditions.
Main Methods:
- Utilized a nested case-control study design with 176 healthy adult participants.
- Employed multivariate analysis of variance (MANOVA) and nonparametric Bayesian additive regression trees.
- Conducted receiver operating characteristic (ROC) curve analysis to assess predictive accuracy.
Main Results:
- Identified a specific profile of immune markers, including Interleukin 8 (IL-8), IL-10, interferon gamma (IFN-γ), and inducible protein 10 (IP-10).
- This immunologic signature was predictive of excessive body weight with an area under the ROC curve of 71% (p < 0.0002).
Conclusions:
- The identified immunologic signature provides a novel approach to defining excessive body weight.
- This profile-based method may enable the identification of unique immunologic characteristics specific to different types of obesity.
Related Concept Videos
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
01:02Hypodermis
The hypodermis (the subcutaneous layer or superficial fascia) is present directly below the dermis. It connects the skin to the underlying fascia (fibrous tissue) of the bones and muscles. It is not strictly a part of the skin, although the border between the hypodermis and dermis can be difficult to distinguish. The hypodermis consists of well-vascularized, loose, areolar connective tissue and adipose tissue, which functions as a mode of fat storage and provides insulation and cushioning for...